Tolvaptan 15mg tablet: Uses, Side Effects, Price |...

TOLVAPTORIS 15 is a specialized medication that contains Tolvaptan 15mg, a vasopressin receptor antagonist used in the treatment of hyponatremia (low sodium levels) and autosomal dominant polycystic kidney disease (ADPKD). This medication works by blocking the action of vasopressin, a hormone responsible for water retention, thereby promoting the excretion of excess water while maintaining sodium balance in the body. As a result, TOLVAPTORIS 15 plays a crucial role in managing fluid balance and supporting kidney function, particularly in patients with chronic conditions.

Key Features and Ingredients:

1. Active Ingredient – Tolvaptan (15mg):
   The active ingredient in TOLVAPTORIS 15 is Tolvaptan, which selectively targets the vasopressin V2 receptors in the kidneys. By inhibiting these receptors, Tolvaptan prevents the action of vasopressin, a hormone that typically promotes water retention and can lead to fluid overload and hyponatremia (low blood sodium).

2. Vasopressin Receptor Antagonism:
   Tolvaptan specifically blocks the V2 receptors, which results in increased urine output without the loss of sodium or potassium, making it an ideal treatment for hyponatremia.

3. Potent and Effective:
   At a 15 mg dose, TOLVAPTORIS 15 delivers the optimal amount of Tolvaptan to manage fluid retention while preserving electrolyte balance, which is essential for preventing complications like electrolyte imbalances and kidney damage.

Usage of Tolvaptan,:

TOLVAPTORIS 15 is prescribed for managing:

1. Hyponatremia:
   Hyponatremia is a condition where there is an abnormally low level of sodium in the blood. This can be caused by various conditions, including heart failure, liver cirrhosis, and kidney disease. TOLVAPTORIS 15 is particularly effective in these cases as it helps restore sodium levels by promoting the excretion of excess water without the loss of sodium.

2. Autosomal Dominant Polycystic Kidney Disease (ADPKD):
   Tolvaptan is the first drug approved to slow the progression of ADPKD, a genetic disorder that causes fluid-filled cysts to grow in the kidneys. By inhibiting vasopressin, TOLVAPTORIS 15 helps to slow the enlargement of these cysts, thus preserving kidney function and reducing the risk of kidney failure.

Dosage: The usual starting dose of TOLVAPTORIS 15 is 15 mg once daily. Based on the patient\'s response and clinical requirements, the dose may be adjusted by a healthcare provider.

Benefits of Tolvaptan:

1. Restores Sodium Balance in Hyponatremia:
   One of the key benefits of TOLVAPTORIS 15 is its ability to correct hyponatremia by increasing sodium levels in the blood. It does so without causing excessive loss of important electrolytes like potassium and sodium, which are often compromised with traditional diuretics.

2. Slows the Progression of ADPKD:
   In patients with autosomal dominant polycystic kidney disease (ADPKD), TOLVAPTORIS 15 helps slow down the growth of kidney cysts, which in turn helps preserve kidney function. By blocking vasopressin, TOLVAPTORIS 15 prevents the hormone from stimulating cyst growth, which is a major contributor to kidney enlargement and eventual kidney failure.

3. Prevents Fluid Overload:
   TOLVAPTORIS 15 promotes the elimination of excess water from the body while maintaining an optimal balance of sodium and other electrolytes. This is particularly beneficial for patients with conditions that lead to fluid retention, such as heart failure, liver cirrhosis, and kidney disease.

4. Non-Diuretic Action:
   Unlike traditional diuretics, which can cause electrolyte imbalances, TOLVAPTORIS 15 works in a non-diuretic way. This means that while it helps the body excrete excess water, it does so without causing significant sodium loss, making it safer for patients with hyponatremia or other fluid retention disorders.

5. Improved Quality of Life:
   For patients with ADPKD, TOLVAPTORIS 15 can help slow the progression of kidney disease, reducing the need for dialysis or kidney transplants in the future. It also helps manage fluid retention and electrolyte levels, improving the patient\'s overall quality of life.

Conclusion:

TOLVAPTORIS 15 (Tolvaptan 15 mg) is an effective and specialized treatment for managing hyponatremia and autosomal dominant polycystic kidney disease (ADPKD). With its vasopressin receptor antagonist action, TOLVAPTORIS 15 offers unique benefits by correcting fluid imbalances, improving sodium levels, and slowing the progression of kidney cysts. It is an essential medication for patients looking to preserve kidney function and maintain a stable electrolyte balance.

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 8209542042 , 8824175417

BUY NOW